Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XDEMVY for Demodex Blepharitis in Contact Lens Wearers
NCT06182358Phase 4Completed
- Sponsor
- Tarsus Pharmaceuticals, Inc.
- Start
- Dec 2023
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of fexuprazan in Demodex blepharitis (DB), sponsored by Tarsus Pharmaceuticals, Inc.. Started Dec 2023; status: completed.
02
Drugs
fexuprazan
03
Conditions
Demodex blepharitis (DB)
Beyond the preview
Go deeper on NCT06182358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06182358.